We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 640

GPs given a clean bill of health to engage in price setting
  • King & Wood Mallesons
  • Australia
  • March 18 2013

The ACCC has granted authorisation to individual General Practitioners (GPs) working in shared practices to allow them to engage in intra-practice


ACCC proposes to reauthorise collective negotiations by rural doctors
  • Corrs Chambers Westgarth
  • Australia
  • September 11 2013

On 28 August 2013, the ACCC issued a draft determination proposing to allow the Rural Doctors Association of Australia (RDAA) and its state


A summary of major developments in key areas - general counsel update - July 2014
  • Herbert Smith Freehills LLP
  • Australia, European Union, Hong Kong, United Kingdom
  • July 15 2014

Legislation, in the form of a Regulation and Directive, has been published in the Official Journal of the European Union which will substantially


Competition law scrutiny of patent settlements a new focus in Australia?
  • DLA Piper LLP
  • Australia
  • October 24 2016

Settlement agreements in patent disputes between pharmaceutical companies may soon face greater competition law scrutiny in Australia. The


Doing business in Australia: An introductory guide
  • PwC Australia
  • Australia, Global, OECD
  • October 20 2016

Australia is the world's sixth largest country, comprising an area of approximately 7.7 million square kilometres. It is a vast continent covering a


Australian Federal Court decides protecting your brand against generic pharmaceuticals is not a misuse of market power
  • Bird & Bird
  • Australia
  • March 18 2015

In a decision which will be welcomed by many pharmaceutical companies the Federal Court of Australia recently dismissed proceedings instituted by the


ACCC allegedly misled by Medicines Australia Code of Conduct
  • Russell Kennedy
  • Australia
  • August 25 2014

We previously reported that Medicines Australia submitted its 18th Edition of the Code of Conduct for approval by the ACCC. Subsequently, the Royal


By the numbers
  • King & Wood Mallesons
  • Australia
  • August 13 2014

The CMA has seen a decline in the overall number of merger decisions in the past year. It made 65 phase 1 merger decisions in 2013-14, down from 100


ACCC v Pfizer some guidance to pharmaceutical companies on navigating competition risk
  • Herbert Smith Freehills LLP
  • Australia
  • March 3 2015

The Federal Court of Australia has recently dismissed the ACCC’s case against pharmaceutical company Pfizer. The ACCC alleged that Pfizer had misused


Below cost pricing?
  • King & Wood Mallesons
  • Australia
  • September 1 2014

According to reports in Friday's Australian FianancialRreview, (Hannah Low, page 32), the ACCC has sought to widen its claim against Pfizer. We